Yong Dai
Corporate Officer/Principal presso PREVAIL THERAPEUTICS INC.
Profilo
Yong Dai is the founder of Frontera Therapeutics (HK) Ltd.
He is currently the Chief Technology Officer at Prevail Therapeutics, Inc. where he has been working since 2019.
Prior to this, he worked as the Senior Director-Process & Analytical Development at uniQure NV from 2015 to 2018 and as the Head-Process Development Commercial Support at Shire Pharmaceuticals LLC from 2009 to 2015.
Dr. Dai received his undergraduate and graduate degrees from Peking University and his doctorate from the Chinese Academy of Sciences.
Posizioni attive di Yong Dai
Società | Posizione | Inizio |
---|---|---|
PREVAIL THERAPEUTICS INC. | Corporate Officer/Principal | 01/02/2019 |
Frontera Therapeutics (HK) Ltd.
Frontera Therapeutics (HK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Frontera Therapeutics, Inc., Frontera Therapeutics (HK) Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company was founded by Yong Dai and Yong Dai has been the CEO since incorporation. | Amministratore Delegato | - |
Precedenti posizioni note di Yong Dai
Società | Posizione | Fine |
---|---|---|
UNIQURE N.V. | Corporate Officer/Principal | 01/03/2018 |
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01/01/2015 |
Formazione di Yong Dai
Peking University | Graduate Degree |
Chinese Academy of Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
UNIQURE N.V. | Health Technology |
Aziende private | 3 |
---|---|
Prevail Therapeutics, Inc.
Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Health Technology |
Frontera Therapeutics (HK) Ltd.
Frontera Therapeutics (HK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Frontera Therapeutics, Inc., Frontera Therapeutics (HK) Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company was founded by Yong Dai and Yong Dai has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Yong Dai